Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Lessons From Lockdown: Perspectives on Hepatitis C Care in the US and Australia

In this call between colleagues, expert faculty discuss what they learned during the COVID-19 pandemic about strategies to care for patients with HCV infection, including patients who inject drugs.
Gregory Dore, MBBS, PhD, FRACP, MPH
Stacey Trooskin, MD, PhD, MPH
Released: October 1, 2021 Expiration: No longer available for credit

Related Content

Expert analysis by Dr Nancy Reau on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 8, 2022

Clinical Care Options (CCO) expert analysis by Dr Stefan Zeuzem on new viral hepatitis data from AASLD 2022

Stefan Zeuzem, MD Released: December 8, 2022

Dr Nancy Reau: practice-changing viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 6, 2022

Clinical Care Options (CCO) podcast with Dr Stefan Zeuzem on key viral hepatitis data from AASLD 2022

Stefan Zeuzem, MD Released: December 6, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grants provided by:
AbbVie
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings